Doseology Sciences Inc.

Research Doseology Sciences Inc. (VU70) on Bullrun: market cap EUR 681.47K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerVU70
ExchangeF
CountryCanada
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 681.47K
Financial periodQ1 2026
RevenueEUR 25.97K
Net income-EUR 418.13K
Free cash flow-EUR 294.57K
Gross margin-1.1%

Valuation Snapshot

latest market cap is EUR 681.47K.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	EUR 77.52K	-EUR 828.33K	-EUR 980.91K	38.2%	n/a	EUR 661.94K	EUR 0	EUR 1.32M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-15	EUR 681.47K	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Doseology Sciences Inc.

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc.

Related stock research

Canada stocks Canada Healthcare stocks A-Z stock index

Other Healthcare stocks

Entheon Biomedical Corp. (1XU) NANOSPHERE HEA.SCIENCES (2CG) MedMira Inc (47M) BRAXIA SCIENTIFIC CORP. (4960) WAVERLEY PHARMA INC. (5GZ) BioVaxys Technology Corp. (5LB0) GLOW LIFETECH CORP. (9DO) NERVGEN PHARMA CORP. (9UA) AbCellera Biologics Inc (ABCL) Appili Therapeutics Inc (APLI) Arch Biopartners Inc (ARCH) Aurinia Pharmaceuticals Inc (AUPH)

Frequently asked questions

What is Doseology Sciences Inc.'s market cap?

Doseology Sciences Inc.'s market capitalization is EUR 681.47K.